HHS-OIG HHS OIG Reviews FDA’s Accelerated Approval of Aducanumab Thomas Sullivan Mar 12, 2025 0 Earlier this year, the United States Department of Health and Human Services Office of the Inspector General (HHS OIG) conducted a…
FDA FDA Releases Draft Guidance on Randomized Controlled Drug Trials in Routine… Thomas Sullivan Nov 1, 2024 0 Recently, the United States Food and Drug Administration (FDA) issued a draft guidance, Integrating Randomized Controlled Trials…
